Evaluating a test for upper extremity exercise capacity in patients with interstitial lung disease

Investigation of the Validity and Reliability of 6-minute Pegboard and Ring Test in Patients With Interstitial Lung Disease

Gazi University · NCT06948916

This study is testing a new exercise test for patients with interstitial lung disease to see if it can better measure their upper body strength and endurance compared to traditional methods.

Quick facts

Study typeObservational
Enrollment34 (estimated)
Ages18 Years to 75 Years
SexAll
SponsorGazi University (other)
Locations1 site (Ankara)
Trial IDNCT06948916 on ClinicalTrials.gov

What this trial studies

This observational study aims to assess the validity and reliability of the 6-minute peg-board and ring test in patients diagnosed with interstitial lung disease (ILD). The test, originally developed for chronic obstructive pulmonary disease patients, evaluates upper extremity functional exercise capacity, which is particularly important for ILD patients who may experience significant desaturation during traditional exercise tests. Conducted at Gazi University, the study will involve patients aged 18 to 75 who meet specific inclusion criteria, with data collection occurring from June 2023 to February 2025. The findings could provide valuable insights into the exercise capacity of ILD patients and improve rehabilitation strategies.

Who should consider this trial

Good fit: Ideal candidates for this study are adults aged 18 to 75 diagnosed with interstitial lung disease according to ATS/ERS criteria.

Not a fit: Patients with acute pulmonary exacerbations, obstructive lung disease, or serious cardiovascular conditions may not benefit from this study.

Why it matters

Potential benefit: If successful, this study could enhance the assessment of exercise capacity in patients with interstitial lung disease, leading to better tailored rehabilitation programs.

How similar studies have performed: While the 6-minute peg-board and ring test has been validated in other patient populations, this specific application in ILD is novel and has not been previously studied.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients diagnosed with ILD according to ATS/ERS criteria,
* Ages between 18 and 75,
* Pulmonary infection during the previous month,
* Participants who voluntarily participated in the study were included.

Exclusion Criteria:

* Patients were excluded if they had:
* Acute pulmonary exacerbation or respiratory infection in the last four weeks
* Obstructive lung disease
* Systemic conditions affecting neurological, neuromuscular, orthopedic, or physical functions
* Recent participation in a planned exercise program (within three months)
* Cognitive impairment affecting exercise test understanding
* Contraindications to exercise testing per the American Sports Medicine Association
* Cancer, renal, or hepatic disease
* Aortic stenosis, complex arrhythmia, or aortic aneurysm
* Serious cardiovascular diseases like uncontrolled hypertension, diabetes, heart failure, or arrhythmia

Where this trial is running

Ankara

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.

View on ClinicalTrials.gov →

Conditions: Interstitial Lung Diseases, Exercise Capacity, Upper Extremity, Interstitial lung diseases, Upper extremity

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.